Jasper Ridge Partners’s Pulmonx LUNG Stock Holding History

Jasper Ridge Partners’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-24,629	Closed	-$886K	–	150
2021 Q3	$886K	Buy	+24,629	New	+$969K	0.04%	106

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

MGM

Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jasper Ridge Partners's LUNG Position: Q4 2021 in Review

Jasper Ridge Partners sold out of Pulmonx (LUNG) in Q4 2021, closing a stake of 24,629 shares — an estimated $886K sold.

Jasper Ridge Partners first reported a position in LUNG in Q3 2021 and held it in 1 quarter. The position peaked at $886K in Q3 2021. 114 funds tracked by Wall St. Rank hold LUNG as of Q4 2021.

Jasper Ridge Partners reported no remaining Pulmonx position as of Q4 2021 after selling out during the quarter.
Jasper Ridge Partners sold 24,629 Pulmonx shares in Q4 2021, an estimated $886K.
Jasper Ridge Partners first reported a position in Pulmonx in Q3 2021 and held it in 1 quarter.
Jasper Ridge Partners's Pulmonx position peaked at $886K in Q3 2021.
114 funds tracked by Wall St. Rank held Pulmonx as of Q4 2021.

Based on Jasper Ridge Partners's 13F filing for Q4 2021, filed 11 Feb 2022.